| HR (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|
 | Without proteinuria (n=4,266) | Proteinuria (N=2,257) | ||||||
Variables | n | All-cause mortality | Expanded CVD-related mortality | Non-expanded CVD-related mortality | n | All-cause mortality | Expanded CVD-related mortality | Non-expanded CVD-related mortality |
Age-adjusted | Â | Â | Â | Â | Â | Â | Â | Â |
Annual mean eGFR (mL/min/1.73m2) | Â | Â | Â | Â | Â | Â | ||
 ≥90 | 2787 | - | - | - | 899 | - |  |  |
 60~89 | 1225 | 1.02 (0.75-1.39) | 1.16 (0.72-1.86) | 0.93 (0.62-1.40) | 756 | 1.42 (1.03-1.96)* | 1.62 (0.97-2.71) | 1.31 (0.86-2.00) |
 15~59 | 254 | 2.22 (1.56-3.18)*** | 2.20 (1.26-3.83)** | 2.28 (1.43-3.63)*** | 602 | 2.51 (1.86-3.39)*** | 3.36 (2.11-5.37)*** | 1.99 (1.34-2.96)*** |
P for trend | Â | <0.001 | 0.01 | 0.009 | Â | <0.001 | <0.001 | <0.001 |
Multivariate-adjusted1 | Â | Â | Â | Â | Â | Â | Â | |
Annual mean eGFR (mL/min/1.73m2) | Â | Â | Â | Â | Â | Â | ||
 ≥90 | 2787 | - | - | - | 899 | - |  |  |
 60~89 | 1225 | 1.13 (0.82-1.54) | 1.33 (0.82-2.16) | 1.00 (0.66-1.52) | 756 | 1.56 (1.12-2.16)** | 1.76 (1.05-2.95)* | 1.45 (0.94-2.22) |
 15~59 | 254 | 2.46 (1.69-3.57)*** | 2.62 (1.47-4.70)** | 2.39 (1.46-3.89)*** | 602 | 2.58 (1.90-3.51)*** | 3.28 (2.04-5.29)*** | 2.14 (1.42-3.22)*** |
P for trend | Â | <0.001 | 0.003 | 0.005 | Â | <0.001 | <0.001 | <0.001 |
Multivariate-adjusted2 | Â | Â | Â | Â | Â | Â | Â | |
Annual mean eGFR (mL/min/1.73m2) | Â | Â | Â | Â | Â | Â | ||
 ≥90 | 2787 | - | - | - | 899 | - | - | - |
 60~89 | 1225 | 1.11 (0.81-1.52) | 1.28 (0.79-2.08) | 1.01 (0.67-1.53) | 756 | 1.53 (1.10-2.12)* | 1.70 (1.02-2.86)* | 1.43 (0.94-2.20) |
 15~59 | 254 | 2.23 (1.51-3.30)*** | 1.98 (1.06-3.69)* | 2.47 (1.49-4.10)*** | 602 | 2.49 (1.83-3.39)*** | 3.15 (1.96-5.09)*** | 2.06(1.37-3.12)*** |
P for trend | Â | <0.001 | 0.04 | 0.006 | Â | <0.001 | <0.001 | <0.001 |